研究者
J-GLOBAL ID:201701020679893850   更新日: 2020年12月17日

ボラ アンキタ

Borah Ankita | Ankita Borah
所属機関・部署:
研究分野 (6件): ナノバイオサイエンス ,  腫瘍生物学 ,  腫瘍診断、治療学 ,  免疫学 ,  分子生物学 ,  生体材料学
研究キーワード (1件): Drug Delivery, Immunotherapy, iPSCs, Cancer Stem Cells, Nanomedicine, Single Cell Transcriptomics
論文 (8件):
  • Eden Mariam Jacob, Ankita Borah, Sindhu C Pillai, D. Sakthi Kumar. Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. Nanomaterials. 2020. 10. 12. 2460-2460
  • Eden Mariam Jacob, Ankita Borah, Amandeep Jindal, Sindhu C. Pillai, Yohei Yamamoto, Toru Maekawa, Dasappan Nair Sakthi Kumar. Synthesis and characterization of citrus-derived pectin nanoparticles based on their degree of esterification. Journal of Materials Research. 2020. 1-9
  • Sindhu C. Pillai, Ankita Borah, Amandeep Jindal, Eden Mariam Jacob, Yohei Yamamoto, D. Sakthi Kumar. BioPerine Encapsulated Nanoformulation for Overcoming Drug-Resistant Breast Cancers. Asian Journal of Pharmaceutical Sciences. 2020
  • Ankita Borah, Sindhu C Pillai, Ankit Rochani, Vivekanandan Palaninathan, Yoshikata Nakajima, Toru Maekawa, Sakthi Kumar. GANT61 and Curcumin loaded PLGA Nanoparticles for GLI-1 and PI3K/Akt Mediated Inhibition in Breast Adenocarcinoma. Nanotechnology. 2020
  • Ankita Borah, Vivekanandan Palaninathan, Aswathy Ravindran Girija, Sivakumar Balasubramanian, Ankit K Rochani, Toru Maekawa, D. Sakthi Kumar. Poly-lactic-co-glycolic acid Nanoformulation of Small Molecule Antagonist GANT61 for Cancer Annihilation by Modulating Hedgehog Pathway. NanoWorld J. 2017
もっと見る
書籍 (1件):
  • Oncogenomics: from Basic Research to Precision Medicine; Targeting the Hedgehog and Notch Signaling Pathways in Cancer Stem Cells.
    Elsevier 2019
講演・口頭発表等 (5件):
  • Nano-medicine based Combination Therapy Targets Hedgehog Signalling and Epidermal Growth Factor Receptor in Breast Cancer Cells
    (41st EORTC-PAMM Winter Meeting, Stockholm, Sweden, February 2020)
  • Polymeric Nanoparticles for Targeting Cancer Stem Cells (CSCs)
    (Horizon 2020 Marie Sklodowska-Curie ITN “Enabling Excellence” International Symposium on Nanoscience and Nanotechnology, Toyo University, Japan, May 2018)
  • Dual-Drug Combination Therapy of GANT61 and Curcumin via Polymeric Nanoparticles for Enhanced Anti-Tumor Activity in Breast Cancer
    (International Conference on Nanomedicine and Nanobiotechnology (ICONAN 2018), Rome, Italy, September 2018)
  • Therapeutic Polymeric Nanoformulation of Hedgehog (Hh) Pathway Antagonist for Potential Anti-Cancer Therapy
    (Summer School in Translational Cancer Research, Albufeira, Portugal, October 2017)
  • Hedgehog (Hh) pathway inhibitor loaded polymeric nanoparticles for anti-cancer therapy
    (Trends in Nanotechnology International Conference (TNT2016), Fribourg, Switzerland, September 2016)
学歴 (3件):
  • 2014 - 2017 東洋大学
  • 2009 - 2011 Tezpur University Masters
  • 2005 - 2008 Gauhati University Bachelors
学位 (1件):
  • PhD (Toyo University)
経歴 (3件):
  • 2017/05 - 現在 東洋大学
  • 2014/06 - 2017/02 東洋大学
  • 2014/09 - 2016/07 東洋大学
委員歴 (1件):
  • 2017/11 - 2021/11 European Association of Cancer Research EACR
受賞 (4件):
  • 2018/02 - Toyo University Inoue Enryo Research Public Grant
  • 2016/02 - Toyo University Inoue Enryo Research Public Grant
  • 2014/03 - Japanese Government, Ministry of Education, Culture, Sports, Science and Technology Monbukagakusho:MEXT
  • 2009/09 - Department of Biotechnology (DBT), India DBT Fellowship for Masters students
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る